Free Trial
CVE:ACST

Acasti Pharma (ACST) Stock Price, News & Analysis

Acasti Pharma logo
C$0.58
+0.01 (+1.75%)
(As of 03/27/2023)

About Acasti Pharma Stock (CVE:ACST)

Key Stats

Today's Range
C$0.56
C$0.58
50-Day Range
C$0.58
C$0.58
52-Week Range
C$0.47
C$1.66
Volume
2,450 shs
Average Volume
6,576 shs
Market Capitalization
C$25.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.

Receive ACST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acasti Pharma and its competitors with MarketBeat's FREE daily newsletter.

ACST Stock News Headlines

The pin that pops the AI bubble
My new documentary explores the background to this pattern and how and why I believe it will almost certainly repeat itself with the AI frenzy. I urge you to watch it before you invest another cent. Again, to be clear, I’m no Chicken Little. Far from it.
ACST Stock Earnings: Acasti Pharma Beats EPS for Q1 2025
Acasti Pharma Inc. (ACST)
Acasti Pharma Inc. Class A
See More Headlines

ACST Stock Analysis - Frequently Asked Questions

Acasti Pharma's stock was trading at C$0.58 at the start of the year. Since then, ACST shares have increased by 0.0% and is now trading at C$0.58.
View the best growth stocks for 2024 here
.

Shares of ACST stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Acasti Pharma investors own include Matinas BioPharma (MTNB), Genius Brands International (GNUS), Tesla (TSLA), Workhorse Group (WKHS), Nikola (NKLA), SCYNEXIS (SCYX) and Block (SQ).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
CIK
N/A
Fax
N/A
Employees
32
Year Founded
N/A

Profitability

Net Income
C$-17,250,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$115,000.00
Cash Flow
C$0.93 per share
Book Value
C$2.17 per share

Miscellaneous

Free Float
N/A
Market Cap
C$25.87 million
Optionable
Not Optionable
Beta
1.22
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (CVE:ACST) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners